News By Tag
News By Location
Follow on Google News
Global Pharmaceutical Company proves validity of AI in life sciences with Pangaea Data
The presentation (https://www.bio-
Over recent years, the adoption of AI technologies such as NLG has increased within many industries as it enables the conversion of computerized data into natural language. It helps put concepts into words and quickly converts raw data into insights. The global NLG market was valued at $336.2 million in 2018 and is expected to register a CAGR of 19.8% from 2019 to 2025.
Also presenting at Bio-IT World, Pangaea Data introduced clinicians and researchers to its novel unsupervised natural language processing (NLP) methods, which are also inherent in PIES and help pharmaceutical companies and healthcare organizations extract intelligence from electronic health records, including clinicians' notes and multi-modal data. PIES was shown to discover new clinical features for characterizing hard to diagnose conditions, which helped in diagnosing patients earlier, finding 50% more undiagnosed or miscoded patients, improving screening success rates by 400% in only 2-3 weeks and saving 80-90% in time.
Dr. Vibhor Gupta, Founder of Pangaea Data, said, "We are very excited to demonstrate the value that PIES brings to the life sciences and healthcare industry, as evidenced by our success story with a leading global pharmaceutical company through their presentation at Bio-IT World, our peer reviewed publications in high impact journals and our investors, which include leading venture capitalists and experts from the pharmaceutical industry."
For more information on Pangaea Data, and peer reviewed publications, visit www.pangaeadata.ai.